RBGLY INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Reckitt Benckiser Group plc

Reckitt Benckiser securities reminder

The law firm of Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Reckitt Benckiser Group plc (“RB Group” or the “Company”) (OTC BB: RBGLY) between July 28, 2014 and April 9, 2019, inclusive (the “Class Period”). [Read more…]

OMCL INVESTORS ALERT:  Lieff Cabraser Announces Securities Class Action Against Omnicell, Inc.

Omnicell Securities

The law firm of Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Omnicell Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL)  between October 25, 2018 and July 11, 2019, inclusive (the “Class Period”). [Read more…]

RBGLY INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Reckitt Benckiser Group plc

The law firm of Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Reckitt Benckiser Group plc (“RB Group” or the “Company”) (OTC BB: RBGLY) between July 28, 2014 and April 9, 2019, inclusive (the “Class Period”). [Read more…]

AOS INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against A.O. Smith Corporation

A.O. Smith Securities Reminder Blog

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased the common stock of A.O. Smith Corporation (“AOS” or the “Company”) (NYSE: AOS) between July 26, 2016 through May 16, 2019, inclusive (the “Class Period”). [Read more…]

ADMS INVESTORS NOTICE: Lieff Cabraser Investigates Claims Against Adamas Pharmaceuticals, Inc.

ADMS INVESTORS NOTICE: Lieff Cabraser Investigates Claims Against Adamas Pharmaceuticals, Inc.

Lieff Cabraser is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (Nasdaq: ADMS), including investors who purchased Adamas common stock directly in the Company’s January 24, 2018 secondary public offering (“SPO”).

Adamas investors who wish to learn more about the investigation should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358. [Read more…]

AOS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against A.O. Smith Corporation

AOS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against A.O. Smith Corporation

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased the common stock of A.O. Smith Corporation (“A.O. Smith” or the “Company”) (NYSE: AOS) between July 26, 2016 through May 16, 2019, inclusive (the “Class Period”). [Read more…]

ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. Securities Blog

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased the common stock of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (Nasdaq: ADMS) directly in the Company’s January 24, 2018 secondary public offering (“SPO”). [Read more…]

INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Indivior PLC

Indivior Securities Reminder

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action has been filed on behalf of investors who purchased or otherwise acquired the securities of Indivior PLC (“Indivior” or the “Company”) (OTC BB: INVVY) between March 10, 2015 and April 9, 2019, inclusive (the “Class Period”). [Read more…]

Plaintiffs Provide Notice to Wells Fargo Shareholders of $320 Million Settlement of Wells Fargo Shareholder Derivative Litigation

Preliminary Approval Granted to $240M Settlement in Wells Fargo Shareholders Derivative Litigation

San Francisco—(BUSINESSWIRE)–IN RE WELLS FARGO & COMPANY SHAREHOLDER DERIVATIVE LITIGATION, Lead Case No. 3:16-cv-05541-JST (N.D. Cal.)

TO: ALL RECORD AND BENEFICIAL OWNERS OF WELLS FARGO & COMPANY COMMON STOCK AS OF FEBRUARY 26, 2019 (THE “RECORD DATE”), WHO CONTINUE TO OWN SUCH SHARES (“WELLS FARGO SHAREHOLDERS”)

YOU ARE HEREBY NOTIFIED, that pursuant to an Order of the United States District Court for the Northern District of California, a hearing will be held on August 1, 2019, at 2 p.m., before the Honorable Jon S. Tigar, United States District Judge, at the United States District Court for the Northern District of California, 450 Golden Gate Avenue, San Francisco, California 94102, for the purpose of determining whether the proposed settlement of the above captioned derivative action (the “Derivative Action”), with a total settlement value of $320 million (as described below), should be approved as fair, reasonable and adequate, and whether a judgment dismissing the Defendants (as identified in the Stipulation of Settlement (“Stipulation”)) from the Derivative Action with prejudice should be entered. [Read more…]

NTNX INVESTORS REMINDER: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Nutanix, Inc.

Nutanix Securities Final Reminder

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Nutanix, Inc. (“Nutanix” or the “Company”) (Nasdaq: NTNX) between March 2, 2018 and February 28, 2019, inclusive (the “Class Period”). [Read more…]

$320M Wells Fargo Derivative Suit Settlement Granted First Round of Approval

Preliminary Approval Granted to $240M Settlement in Wells Fargo Shareholders Derivative Litigation

A California federal judge has granted preliminary approval to a proposed $320 million settlement that would end shareholders’ derivative litigation relating to Wells Fargo’s fake accounts scandal. Plaintiffs in the suit, including the Fire & Police Pension Association of Colorado and the City of Birmingham Retirement and Relief System allege that since at least 2011, the Board and executive management of Wells Fargo knew or consciously disregarded that its employees were illicitly creating millions of deposit and credit card accounts for their customers, without those customers’ consent, in order to meet aggressive sales goals. [Read more…]

INVVY INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Indivior PLC

Lieff Cabraser Announces Securities Class Action Against Indivior plc

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Indivior PLC (“Indivior” or the “Company”) (INVVY) between March 10, 2015 and April 9, 2019, inclusive (the “Class Period”). If you purchased or otherwise acquired Indivior securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than June 24, 2019. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the actions.

[Read more…]

NTNX INVESTORS Notice: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Nutanix, Inc.

Nutanix Securities Reminder

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Nutanix, Inc. (“Nutanix” or the “Company”) (Nasdaq: NTNX) between March 2, 2018 and February 28, 2019, inclusive (the “Class Period”). [Read more…]

NTNX INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Nutanix, Inc.

Nutanix Securities

SAN FRANCISCO, CA – (April 12, 2019) – Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Nutanix, Inc. (“Nutanix” or the “Company”) (Nasdaq: NTNX) between March 2, 2018 and February 28, 2019, inclusive (the “Class Period”). [Read more…]

INGN INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Inogen, Inc.

Inogen Securities Blog

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Inogen, Inc. (“Inogen” or the “Company”) (Nasdaq: INGN) between November 8, 2017 and February 26, 2019, inclusive (the “Class Period”). [Read more…]

Lieff Cabraser to Proceed with Lawsuit in Denmark for Money Laundering Fraud Against Danske Bank

Securities and financial fraud

Lieff Cabraser, working with an international coalition of law firms including Danish law firm Németh Sigetty, will proceed with a lawsuit against Danske Bank A/S (“Danske” or the “Bank”) to pursue compensation for damaged investors after revelations of alleged money laundering, financial mismanagement, and deficient regulatory disclosures. [Read more…]

The Intercept: Will Shareholders Lose the Right to Sue Over Corporate Fraud?

Securities and financial fraud

In partnership with the Investigative Fund, The Intercept has published a powerful piece calling attention to proposed changes to the securities laws that may keep shareholders from being able to sue corporations that violate the law to shareholders’ detriment. The right to a trial may be replaced with mandatory arbitration agreements that will shunt shareholder lawsuits into private, closed-door arbitration funded by the very corporations alleged to have committed the fraud. [Read more…]

“Where are the Gatekeepers?” Bruce Leppla to Speak at the Investment Company Institute May 2017 General Members Meeting

Bruce Leppla to Speak at the Investment Company Institute May 2017 General Members Meeting

Lieff Cabraser attorney Bruce W. Leppla will be speaking at the Investment Company Institute’s May 4, 2017 General Members Meeting on “Where are the Gatekeepers? The Need for Investment Firm Oversight of the Capital Markets.” Mr. Leppla and his partners represent institutional investors in major class and opt-out investment loss recovery litigation in circumstances where such losses are due to fraud or serious corporate misconduct. [Read more…]

Michael Miarmi to Discuss Fraud-on-the-Market Theory

Michael Miarmi to Discuss Fraud-on-the-Market Theory

Lieff Cabraser attorney Michael Miarmi will participate in a live CLE webcast addressing landmark securities fraud decisions on December 17, 2015. “Fraud-on-the-Market Theory: Presumption and Other Significant Issues and Updates in 2016 and Beyond Live Webcast” will be held on Thursday, December 17 from noon to 12 p.m. (Eastern). The discussion will center around the June 2014 U.S. Supreme Court decision in Halliburton Co. v. Erica P. John Fund, Inc. in which the foundation of securities class actions was called into question. [Read more…]

Bruce Leppla to Speak at the Legal Executive Institute

Bruce Leppla to Speak at the Legal Executive Institute on Intellectual Property Valuation Issues in Merger and Acquisition Litigation

Lieff Cabraser attorney Bruce W. Leppla will be speaking at the Legal Executive Institute’s October 8, 2015 meeting on Board of Director fiduciary duties related to intellectual property valuation in the context of merger and acquisition (M&A) activity. With the dramatic rise of M&A activity involving the acquisition of companies with valuable intellectual property, the issue arises as to whether the Board of the company to be acquired has taken appropriate steps to value its intellectual property. Conventional valuation methods (e.g., discounted cash flow analysis, the use of comparables, etc.) may be of limited help. Mr. Leppla will examine the legal standards with respect to board fiduciary duty in this area and also review new, more innovative financial methods to assess valuation.

[Read more…]